U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07881055) titled 'Cryptococcosis Associated With Bruton Tyrosine Kinase Inhibitors' on Sept. 07.
Brief Summary: The purpose of this study is to describe the clinical, biological, and radiographic characteristics at the time of cryptococcosis diagnosis, as well as the time interval between the initiation of BTK inhibitor therapy and the diagnosis of cryptococcosis.
And also, the clinical course of each patient at 12 months in order to evaluate the susceptibility to cryptococcosis correlated with BTK inhibitor therapy.
Study Start Date: Oct., 2026
Study Type: OBSERVATIONAL
Condition:
Cryptococcosis
Recruitment Status: NOT_YET_RECRUITING
Sponsor:...